Clinical Research Directory

Inclusion Criteria: * VA-eligible Veterans * Ages ≥ 18 * Current diagnosis of opioid use disorder per DSM-5 by clinician assessment * Scheduled to initiate, or has initiated within the past five days, treatment for OUD with buprenorphine/naloxone Exclusion Criteria: * Injury or nerve damage at the arm or palm and/or neuropathy in the upper extremities * Pregnant or planning to become pregnant * Currently implanted with an electrical and/or neurostimulator device (e.g. pacemaker, defibrillator, vagal neurostimulator, deep brain stimulator, spinal stimulator, sacral stimulator, bone growth stimulator, or cochlear implant) * Use of an investigational drug/device therapy within the past 4 weeks * History of epilepsy or a seizure disorder * Has an electrically conductive metal object (e.g. jewelry) that cannot be removed and will directly contact the gel electrodes of the Empower Neuromodulation System when applied to the skin at the stimulation location * Unable to provide informed written consent * Has taken a medication-assisted treatment (MAT) for OUD in the past two weeks or plans to take any prescription opioid or MAT for OUD other than buprenorphine/naloxone while enrolled in the study * Is deemed unsuitable for enrollment in the study by the PI (e.g. current medical or psychiatric instability)